Metastatic parathyroid carcinoma initially misdiagnosed as parathyroid adenoma: the role of parafibromin in increasing diagnostic accuracy
Version of Record online: 8 SEP 2011
© 2011 The Authors. Internal Medicine Journal © 2011 Royal Australasian College of Physicians
Internal Medicine Journal
Volume 41, Issue 9, pages 695–699, September 2011
How to Cite
Lim, S., Elston, M. S., Gill, A. J., Marsh, D. J. and Conaglen, J. V. (2011), Metastatic parathyroid carcinoma initially misdiagnosed as parathyroid adenoma: the role of parafibromin in increasing diagnostic accuracy. Internal Medicine Journal, 41: 695–699. doi: 10.1111/j.1445-5994.2011.02545.x
Conflict of interest: None.
- Issue online: 8 SEP 2011
- Version of Record online: 8 SEP 2011
- Received 19 March 2010; accepted 7 July 2010.
- parathyroid carcinoma;
- parathyroid adenoma;
- HRPT2 (CDC73)
Parathyroid carcinoma, although a rare cause of primary hyperparathyroidism, carries a significant morbidity and mortality from severe symptomatic hypercalcaemia and related complications. We report a case where the diagnosis was not considered from the outset and review the current clinical and histopathological markers available to assist in the diagnosis of parathyroid carcinoma.